Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: Results of a randomized clinical trial

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 12, 2005, Pages 1369-1377

  Wenger, Urs ^a   Johnsson, Erik ^b   Bergquist, Henrik ^b   Nyman, Jan ^b   Ejnell, Hans ^b   Lagergren, Jesper ^a   Ruth, Magnus ^b   Lundell, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brachytherapy; Health economic evaluation; Oesophageal neoplasm; Palliative care; Stents

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSPHAGIA; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STENT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COST-BENEFIT ANALYSIS; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 29244478891     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200512000-00017     Document Type: Article

References (35)

1. Wenger U, Luo J, Lundell L, Lagergren J. A nationwide study of the use of self-expanding stents in patients with esophageal cancer in Sweden. Endoscopy 2005; 37:329-334.
2. Knyrim K, Wagner H-J, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329:1302-1307.
3. De Palma GD, di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 1996; 43:478-482.
4. Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998; 47:113-120.
5. Siersema PD, Hop WC, van Blankenstein M, Dees J. A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. Gastrointest Enclosc 2000; 51:139-145.
6. Siersema P, Hop W, van Blankenstein M, van Tilburg A, Bac D-J, Homs M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54:145-153.
7. Riccioni ME, Shah SK, Tringali A, Ciletti S, Mutignani M, Perri V, et al. Endoscopic palliation of unresectable malignant oesophageal strictures with self-expanding metal stents: comparing Ultraflex and Esophacoil stents. Dig Liver Dis 2002; 34:356-363.
8. Kozarek RA, Ball TJ, Brandabur JJ, Patterson DJ, Low D, Hill L, et al. Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 1996; 43:204-208.
9. Christie NA, Buenaventura PO, Fernando HC, Nguyen NT, Weigel TL, Person PF, et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg 2001; 71:1797-1801; discussion 1801-1802.
10. Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 2001; 12:465-474.
11. Neale JC, Goulden JW, Allan SG, Dixon PD, Isaacs RJ. Esophageal stents in malignant dysphagia: a two-edged sword? J Palliat Care 2004; 20:28-31.
12. Brewster AE, Davidson SE, Makin WP, Stout R, Burt PA. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 1995; 7:102-105.
13. Jager J, Langendijk H, Pannebakker M, Rijken J, de Jong J. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol 1995; 37:237-240.
14. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1998; 40:447-453.
15. Sharma V, Mahantshetty U, Dinshaw KA, Deshpande R, Sharma S. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2002; 52:310-315.
16. Bergquist H. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastro-esophageal junction. Results of a randomised controlled clinical trial. Dis Esophagus 2005; 18:131-139.
17. Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004; 364:1497-1504.
18. Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut 1982; 23:1060-1067.
19. Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 2004; 100:1967-1977.
20. Lundell L, Leth R, Lind T, Lonroth H, Sjovall M, Olbe L. Palliative endoscopic dilatation in carcinoma of the esophagus and esophagogastric junction. Acta Chir Scand 1989; 155:179-184.
21. Sihvo El, Pentikainen T, Luostarinen ME, Ramo OJ, Salo JA. Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis. Eur J Surg Oncol 2002; 28:711-715.
22. Dallal H, Smith G, Grieve D, Ghosh S, Penman I, Palmer K. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001; 54:549-557.
23. Aoki T, Osaka Y, Takagi Y, Okada R, Shinohara M, Tsuchida A, et al. Comparative study of self-expandable metallic stent and bypass surgery for inoperable esophageal cancer. Dis Esophagus 2001; 14:208-211.
24. Whooley BP, Law S, Murthy SC, Alexandrou A, Chu KM, Wong J. The Kirschner operation in unresectable esophageal cancer: current application. Arch Surg 2002; 137:1228-1232.
25. Homs MY, Eijkenboom WM, Coen VL, Haringsma J, van Blankenstein M, Kuipers EJ, et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003; 66:327-332.
26. Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 2002; 53:127-133.
27. Profili S, Meloni GB, Feo CF, Pischedda A, Bozzo C, Ginesu GC, et al. Self-expandable metal stents in the management of cervical oesophageal and/or hypopharyngeal strictures. Clin Radiol 2002; 57:1028-1033.
28. Macdonald S, Edwards RD, Moss JG. Patient tolerance of cervical esophageal metallic stents. J Vasc Interv Radiol 2000; 11:891-898.
29. Siersema PD, Schrauwen SL, van Blankenstein M, Steyerberg EW, van der Gaast A, Tilanus HW, et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 2001; 54:579-586.
30. Waring JP, Baron TH, Hirota WK, Goldstein JL, Jacobson BC, Leighton JA, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 2003; 58:317-322.
31. May A, Hahn EG, Ell C. Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin Gastroenterol 1996; 22:261-266.
32. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003; 52:922-926.
33. Polinder S, Homs MY, Siersema PD, Steyerberg EW. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer 2004; 90:2067-2072.
34. Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speiser B. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys 1997; 38:127-132.
35. Rowland CG, Pagliero KM. Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia. Lancet 1985; ii:981-983.